TrialAnnals of the rheumatic diseases2016

Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis.

Joshua F Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.